Holen Sie sich die Stockscreener-App
0.8664
1.47%
-0.0129
Schlusskurs vom Vortag:
$0.8793
Offen:
$0.86
24-Stunden-Volumen:
542.78K
Relative Volume:
0.63
Marktkapitalisierung:
$170.43M
Einnahmen:
-
Nettoeinkommen (Verlust:
$52.50M
KGV:
29.77
EPS:
0.0291
Netto-Cashflow:
$-4.13M
1W Leistung:
-4.79%
1M Leistung:
-13.23%
6M Leistung:
-27.19%
1J Leistung:
+92.53%
1-Tages-Spanne:
$0.86
$0.9068
1-Wochen-Bereich:
$0.8534
$0.95
52-Wochen-Spanne:
$0.2556
$3.09
Tevogen Bio Holdings Inc Stock (TVGN) Company Profile
Firmenname
Tevogen Bio Holdings Inc
Sektor
Branche
Telefon
646-807-8832
Adresse
15 INDEPENDENCE BOULEVARD, SUITE #210, WARREN
Vergleichen Sie TVGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TVGN
Tevogen Bio Holdings Inc
|
0.8664 | 172.96M | 0 | 52.50M | -4.13M | 0.0291 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Tevogen Bio Holdings Inc Stock (TVGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-04 | Eingeleitet | D. Boral Capital | Buy |
Tevogen Bio Holdings Inc Aktie (TVGN) Neueste Nachrichten
Combining price and volume data for Tevogen Bio Holdings Inc. Equity WarrantPortfolio Performance Report & AI Forecast Swing Trade Picks - Newser
What are the analyst revisions for Tevogen Bio Holdings Inc.Is LIND stock a good investment in YEAR - خودرو بانک
What the charts say about Tevogen Bio Holdings Inc. todayJuly 2025 PostEarnings & Safe Entry Trade Reports - Newser
Ideas Watch: What analysts say about Tevogen Bio Holdings Inc. stock2025 Technical Overview & Real-Time Buy Signal Notifications - خودرو بانک
Can Tevogen Bio Holdings Inc. Equity Warrant outperform in the next rallyWeekly Investment Report & Advanced Swing Trade Entry Alerts - خودرو بانک
Can Tevogen Bio Holdings Inc. withstand a market correctionWeekly Investment Summary & Growth Oriented Trading Recommendations - خودرو بانک
Live market analysis of Tevogen Bio Holdings Inc. Equity Warrant2025 EndofYear Setup & Safe Capital Allocation Plans - Newser
Real time scanner hits for Tevogen Bio Holdings Inc. explainedWeekly Risk Summary & Weekly Watchlist for Hot Stocks - Newser
Using Ichimoku Cloud for Tevogen Bio Holdings Inc. technicalsWeekly Risk Summary & Weekly Market Pulse Alerts - Newser
What are the risks of holding Tevogen Bio Holdings Inc.2025 Trading Volume Trends & Intraday High Probability Setup Alerts - خودرو بانک
Is Tevogen Bio Holdings Inc. part of any ETFJuly 2025 Price Swings & Advanced Swing Trade Entry Plans - خودرو بانک
Comparing Tevogen Bio Holdings Inc. Equity Warrant in custom built stock radarsLong Setup & Fast Entry and Exit Trade Plans - Newser
What are Tevogen Bio Holdings Inc.’s recent SEC filings showingGap Up & Safe Entry Zone Identification - خودرو بانک
Pullback Watch: What is Tevogen Bio Holdings Inc.’s book value per shareTrade Exit Summary & Entry Point Strategy Guides - خودرو بانک
Tevogen shares EBV treatment forecast with $3.5 billion revenue potential By Investing.com - Investing.com Australia
Quantitative breakdown of Tevogen Bio Holdings Inc. recent moveWeekly Market Outlook & Entry Point Confirmation Signals - Newser
How institutional ownership impacts Tevogen Bio Holdings Inc. Equity Warrant stockMarket Sentiment Report & Community Trade Idea Sharing Platform - Newser
Can technical indicators confirm Tevogen Bio Holdings Inc. Equity Warrant’s reversalMarket Risk Analysis & Real-Time Volume Trigger Notifications - Newser
Order flow analysis tools used on Tevogen Bio Holdings Inc.Market Rally & Risk Managed Investment Strategies - Newser
Press Release: REPEAT -- Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts - 富途牛牛
Tick level data insight on Tevogen Bio Holdings Inc. Equity Warrant volatilityAnalyst Downgrade & Entry and Exit Point Strategies - Newser
How to read the order book for Tevogen Bio Holdings Inc. Equity WarrantEntry Point & High Return Stock Watch Alerts - Newser
What earnings revisions data tells us about Tevogen Bio Holdings Inc. Equity WarrantWeekly Trade Summary & Community Consensus Picks - Newser
Is now a turning point for Tevogen Bio Holdings Inc. Equity Warrant2025 Volatility Report & Daily Growth Stock Investment Tips - Newser
Can you recover from losses in Tevogen Bio Holdings Inc.2025 Support & Resistance & Fast Entry Momentum Alerts - Newser
Intraday pattern recognizer results for Tevogen Bio Holdings Inc. Equity WarrantJuly 2025 Snapshot & Stepwise Entry/Exit Trade Alerts - Newser
Should you wait for a breakout in Tevogen Bio Holdings Inc. Equity Warrant2025 Analyst Calls & AI Driven Stock Reports - Newser
Is it too late to sell Tevogen Bio Holdings Inc.2025 Buyback Activity & Weekly Chart Analysis and Guides - Newser
Is Tevogen Bio Holdings Inc. Equity Warrant in a long term uptrendJuly 2025 Snapshot & Comprehensive Market Scan Reports - خودرو بانک
Is Tevogen Bio Holdings Inc. Equity Warrant stock overvalued or fairly pricedJuly 2025 Retail & Stock Market Timing Techniques - خودرو بانک
Will Tevogen Bio Holdings Inc. Equity Warrant benefit from macro trendsBuy Signal & Accurate Entry/Exit Alerts - Newser
Tevogen shares EBV treatment forecast with $3.5 billion revenue potential - Investing.com
Tevogen Shares Valuation of Key Assets and Potential - GlobeNewswire
What is the dividend yield of Tevogen Bio Holdings Inc. Equity WarrantMarket Trend Review & AI Based Trade Execution Alerts - خودرو بانک
Inmune Bio Inc. shares rise 1.02% premarket after Tevogen Bio Holdings Inc. highlights the importance of SARS-CoV-2 treatments for weakened immune systems. - AInvest
Tools to monitor Tevogen Bio Holdings Inc. recovery probability2025 Year in Review & High Accuracy Trade Alerts - Newser
Tevogen Bio Holdings Inc. stock daily chart insightsDividend Hike & Stepwise Trade Execution Plans - Newser
Identifying reversal signals in Tevogen Bio Holdings Inc. Equity WarrantMarket Movement Recap & Pattern Based Trade Signal System - Newser
How to escape a deep drawdown in Tevogen Bio Holdings Inc.Portfolio Risk Summary & Safe Entry Trade Signal Reports - Newser
Is Tevogen Bio Holdings Inc. stock bottoming outForecast Cut & High Win Rate Trade Alerts - Newser
Is Tevogen Bio Holdings Inc. Equity Warrant trending in predictive chart modelsIndex Update & Weekly Breakout Stock Alerts - Newser
How to monitor Tevogen Bio Holdings Inc. Equity Warrant with trend dashboardsWeekly Market Summary & Safe Capital Allocation Plans - Newser
Why Tevogen Bio Holdings Inc. stock attracts strong analyst attention2025 Short Interest & Daily Risk Controlled Trade Plans - Newser
How cyclical is Tevogen Bio Holdings Inc. Equity Warrant’s revenue streamCPI Data & Weekly High Momentum Picks - خودرو بانک
Chart based analysis of Tevogen Bio Holdings Inc. trendsGlobal Markets & Fast Gain Stock Tips - Newser
Is Tevogen Bio Holdings Inc. a speculative investmentQuarterly Portfolio Summary & Long-Term Capital Growth Strategies - خودرو بانک
Downgrade Watch: Can Tevogen Bio Holdings Inc. Equity Warrant outperform in the next rallyQuarterly Earnings Summary & Technical Confirmation Trade Alerts - خودرو بانک
Tevogen highlights need for SARS-CoV-2 treatments for immunocompromised - Investing.com
Tevogen Bio Highlights Promising Clinical Results for TVGN 489 in Treating SARS-CoV-2 in Immunocompromised Patients - Quiver Quantitative
Tevogen Underscores the Importance of Precision - GlobeNewswire
99% COVID Elimination: Tevogen's Novel T Cell Therapy Shows Promise for Immunocompromised Patients - Stock Titan
Finanzdaten der Tevogen Bio Holdings Inc-Aktie (TVGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):